The Andersons' Director Conducts Multiple Sales to Close 2025

The Andersons reported insider activity in December 2025: director John T. Stout Jr. executed an open-market sale of 12,500 shares on Dec. 10 for roughly $647,088 (first open-market sale in two years) and continued selling to leave 25,940.57 direct shares (~$1.45M), while CEO William E. Krueger gifted 38,200 shares. Company fundamentals show $11.60B revenue (TTM), $73.37M net income (TTM), a 1.38% dividend yield and a ~33.9% one‑year price gain; management unveiled a plan on Dec. 11 targeting a 36% CAGR in EPS from $2.56 to $7 by 2028 with a $60M ethanol-plant expansion, despite four consecutive quarters of year-over-year EPS declines (including -26.25% in Q3 2025). Upcoming Q4 results on Feb. 17, 2026 are a near-term catalyst to validate the guidance and capital-investment strategy.

Analysis

Market structure: The Andersons (ANDE) stands to gain if execution of its $60M ethanol expansion and export-terminal investments accelerate capture of downstream margins; a 30M gallon boost equals ~0.19% of U.S. annual ethanol output (30M/16B), so national price impact is minimal but regional terminal/logistics pricing power can improve. Winners: ANDE, regional terminal operators, logistics providers; losers: pure commodity-exposed ethanol/grain producers if logistics capture more spread. Cross-asset: expect elevated equity options IV into the Feb. 17 Q4 print, modest move in corporate credit spreads on any guidance miss, and corn/ethanol prices to drive fundamentals (corn spikes >10% would compress ethanol margins).

Risk assessment: Insider selling by Director John Stout Jr. reduced his direct stake ~22% in December, a material liquidity signal that raises governance/execution questions but could be personal/tax-driven. Tail risks: RFS/regulatory rollback, a >10% corn price shock, or capex/commissioning delay that pushes 2028 EPS trajectory off-target. Time horizons: immediate (days) — sentiment/volatility drift; short (weeks–months) — Feb. 17 earnings; long (years) — execution to 2028 36% CAGR target.

trade implications: Tactical: establish a small, conviction-weighted long in ANDE (2–3% portfolio) ahead of Feb. 17, add to 5% only if Q4 shows sequential EPS/margin improvement or management reiterates midpoint progress; hard stop -12% from entry. Options: for defined risk, buy Mar 2026 $55 calls (0.5–1% portfolio) as a leveraged upside; hedge with Feb 2026 $45 puts (size 0.5%) if EPS guidance misses. Pair: long ANDE (2%) vs short GPRE (Green Plains) (1.5%) to favor infrastructure over pure producer exposure.

contrarian angles: The market may over-interpret one director’s ~22% stake reduction as structural weakness; many insider disposals are liquidity/tax events and CEO’s gifting is non-sale. If ANDE delivers even modest sequential EPS recovery (single-quarter reversal of the four-quarter EPS decline) the stock could re-rate; conversely, an ambitious 2028 EPS goal creates binary outcomes — small, asymmetric option-sized positions capture upside while capping downside.

Key Decisions for Investors

• Establish a 2–3% long position in ANDE ahead of Feb. 17, 2026 earnings; add up to 5% total only if Q4 shows sequential EPS improvement and management reaffirms 2028 guidance; use a hard stop at -12% from entry.
• Initiate a paired trade: long ANDE 2% vs short GPRE (Green Plains) 1.5% to express preference for integrated logistics/infrastructure over pure ethanol production; reweight after earnings or if corn prices move >+10%.
• Buy Mar 2026 ANDE $55 calls sized 0.5–1% of portfolio as leveraged upside exposure; concurrently buy Feb 2026 ANDE $45 puts sized 0.5% as earnings-event hedge if guidance is missed.
• If ANDE’s Feb. 17 EPS misses consensus by >10% or management delays capex/timelines, reduce ANDE exposure to zero and rotate 2–4% portfolio into regional ag logistics names with stronger free cash flow (e.g., CHRW-like profiles).